Sumoylation: Implications for Neurodegenerative Diseases

被引:51
作者
Anderson, Dina B. [1 ]
Zanella, Camila A. [2 ]
Henley, Jeremy M. [3 ]
Cimarosti, Helena [2 ]
机构
[1] Ipsen Bioinnovat Ltd, Units Quadrant 4 10, Barton Lane, Abingdon OX14 3YS, Oxon, England
[2] Univ Fed Santa Catarina, Dept Pharmacol, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil
[3] Univ Bristol, Sch Biochem, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England
来源
SUMO REGULATION OF CELLULAR PROCESSES, 2ND EDITION | 2017年 / 963卷
基金
英国惠康基金; 英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
Alzheimer's disease; Amyotrophic lateral sclerosis; Ischemia; Neuronal intranuclear inclusion disease; Parkinson's disease; Polyglutamine diseases; Drug targets; INTRANUCLEAR INCLUSION DISEASE; ALPHA-SYNUCLEIN AGGREGATION; FAMILIAL PARKINSONS-DISEASE; MODIFIER SUMO MODIFICATION; A-BETA GENERATION; PROTEIN SUMOYLATION; ENHANCED SUMOYLATION; ALZHEIMERS-DISEASE; ANDROGEN RECEPTOR; MOUSE MODEL;
D O I
10.1007/978-3-319-50044-7_16
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The covalent posttranslational modifications of proteins are critical events in signaling cascades that enable cells to efficiently, rapidly and reversibly respond to extracellular stimuli. This is especially important in the CNS where the processes affecting synaptic communication between neurons are highly complex and very tightly regulated. Sumoylation regulates the function and fate of a diverse array of proteins and participates in the complex cell signaling pathways required for cell survival. One of the most complex signaling pathways is synaptic transmission. Correct synaptic function is critical to the working of the brain and its alteration through synaptic plasticity mediates learning, mental disorders and stroke. The investigation of neuronal sumoylation is a new and exciting field and the functional and pathophysiological implications are far-reaching. Sumoylation has already been implicated in a diverse array of neurological disorders. Here we provide an overview of current literature highlighting recent insights into the role of sumoylation in neurodegeneration. In addition we present a brief assessment of drug discovery in the analogous ubiquitin system and extrapolate on the potential fordevelopment of novel therapies that might target SUMO-associated mechanisms of neurodegenerative disease.
引用
收藏
页码:261 / 281
页数:21
相关论文
共 149 条
  • [61] Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells
    Lee, Yang-ja
    Miyake, Shin-ichi
    Wakita, Hideaki
    McMullen, David C.
    Azuma, Yoshiaki
    Auh, Sungyoung
    Hallenbeck, John M.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (05) : 950 - 962
  • [62] Global SUMOylation is a molecular mechanism underlying hypothermia-induced ischemic tolerance
    Lee, Yang-ja
    Mou, Yougshan
    Klimanis, Dace
    Bernstock, Joshua D.
    Hallenbeck, Johnm.
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [63] SUMO and Ischemic Tolerance
    Lee, Yang-ja
    Hallenbeck, John M.
    [J]. NEUROMOLECULAR MEDICINE, 2013, 15 (04) : 771 - 781
  • [64] Elevated Global SUMOylation in Ubc9 Transgenic Mice Protects Their Brains against Focal Cerebral Ischemic Damage
    Lee, Yang-Ja
    Mou, Yongshan
    Maric, Dragan
    Klimanis, Dace
    Auh, Sungyoung
    Hallenbeck, John M.
    [J]. PLOS ONE, 2011, 6 (10):
  • [65] SUMOylation participates in induction of ischemic tolerance
    Lee, Yang -ja
    Castri, Paola
    Bembry, Joliet
    Maric, Dragan
    Auh, Sungyoung
    Hallenbeck, John M.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2009, 109 (01) : 257 - 267
  • [66] The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death
    Leitao, Beatriz B.
    Jones, Marius C.
    Brosens, Jan J.
    [J]. FASEB JOURNAL, 2011, 25 (10) : 3416 - 3425
  • [67] Positive and negative regulation of APP amyloidogenesis by sumoylation
    Li, YH
    Wang, H
    Wang, S
    Quon, D
    Liu, YW
    Cordell, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) : 259 - 264
  • [68] Lieberman AP, 1999, ANN NEUROL, V46, P271, DOI 10.1002/1531-8249(199908)46:2<271::AID-ANA21>3.0.CO
  • [69] 2-M
  • [70] Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease
    Lieberman, AP
    Robitaille, Y
    Trojanowski, JQ
    Dickson, DW
    Fischbeck, KH
    [J]. LANCET, 1998, 351 (9106) : 884 - 884